Science
Mechanism of Action
The extract's purported mechanism in skincare is linked to its complex alkaloid profile, featuring compounds such as corydaline, berberine, protopine, and palmatine, which are broadly associated with analgesic, anti-spasmodic, and anti-inflammatory biological activities. Dehydrobulbine (DHCB), another identified alkaloid, has been specifically implicated in reducing inflammatory pain. While its function is broadly described as 'skin conditioning', specific evidence detailing its direct impact on mechanisms like MMP-1 inhibition (fine line reduction), lipoxygenase activity (sebum control), tyrosinase activity (hyperpigmentation reduction), or oxidative damage protection within topical skincare formulations is not currently available in the provided research.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
There is no information to suggest this ingredient is commonly used in concentrations below its effective threshold merely for marketing purposes.
The Formula
Formulation
Stability
The stability and specific chemical forms of alkaloids within *Corydalis* extracts are influenced by pH, with notable differences observed under both highly basic (pH 10.5) and acidic (pH 3.0) conditions for *Corydalis yanhusuo* alkaloids. However, an optimal pH range for ensuring the stability of *Corydalis ambigua bark/root extract* specifically in topical skincare formulations has not been specified.
Safety
Safety Profile
There is no specific safety assessment available from regulatory bodies such as CIR or SCCS for *Corydalis Ambigua Bark/Root Extract* as a topical cosmetic ingredient. While the FDA does not regulate cosmetic ingredients in the same manner as pharmaceuticals, no dedicated FDA status was identified. Concerns regarding oral ingestion of extracts from related *Corydalis* species, particularly *Corydalis yanhusuo*, include associations with severe liver injury and central nervous system suppression from alkaloids like tetrahydropalmatine (THP). Berberine, another prevalent alkaloid, may pose risks to newborns and interfere with liver function. Raw *C. yanhusuo* extracts taken orally have also been linked to mild hepatotoxicity. It is important to emphasize that these safety concerns primarily pertain to oral intake and may not directly translate to topical application. However, due to the limited specific topical safety data for *Corydalis ambigua bark/root extract*, a cautious approach is advised.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While *Corydalis ambigua bark/root extract* demonstrates potential for skin conditioning and anti-inflammatory benefits due to its alkaloid profile, its classification for Moumoujus remains under review due to a current lack of specific, robust topical efficacy and safety data.
Related
Similar Ingredients
Finding similar ingredients…